Policy Reporter by Mercalis and AccessSync Announce Strategic Partnership to Transform Market Access Capabilities

Collaboration integrates comprehensive payer policy intelligence with Access Realization™ solutions to overcome market access complexity for life sciences products

MORRISVILLE, N.C., April 1, 2025 /PRNewswire/ -- Policy Reporter by Mercalis, the industry-leading provider of payer policy intelligence and market access insights, today announced a strategic partnership with AccessSync, a healthcare technology company focused on helping life sciences manufacturers overcome market access complexities to enable innovative products to reach more patients.

This partnership will integrate Policy Reporter's extensive payer landscape dashboard and API-delivered curated payer data with AccessSync® One, an integrated market access platform, creating a powerful solution for life sciences manufacturers seeking to overcome market access challenges through a unified, full-picture view of critical market access data.

"By joining forces with AccessSync, we're enhancing our ability to deliver actionable payer intelligence through our dashboarding and API capabilities," said Tim Ogren, General Manager of Policy Reporter by Mercalis. "This integration allows pharmaceutical, medical device, and diagnostic manufacturers to not only track payer policies and coverage criteria, but also directly address market access complexity with a unified 'single source of truth' for all market access information."

The partnership will offer market access teams:

• Seamless integration of Policy Reporter's comprehensive payer policy database with the AccessSync One integrated market access platform
• Enhanced payer landscape dashboards providing a holistic view of factors impacting patient access such as policy, formulary, and prior authorization information
• Real-time alerts on policy changes affecting specific products, payers, and plan types (Commercial, Medicare, Medicaid)
• API-enabled distribution of curated payer data for pre-call planning with access insights at territory and HCP levels
• Dynamic creation and distribution of data-driven access resources for field teams, including direct links to relevant Policy Reporter documents

"AccessSync is focused on Access Realization solutions that enable life sciences companies to successfully navigate market access complexity," said Tate Rarick, Managing Director of AccessSync. "Our partnership with Policy Reporter creates a powerful combination to help close the gap between potential and actual patient access to essential therapies, providing clients with comprehensive policy intelligence seamlessly integrated into planning and pull-through tools."

The companies are currently supporting select clients with this integrated data-driven solution, and additional API capabilities and enhancements to both organizations' platforms are planned throughout the year.

About Policy Reporter by Mercalis

Policy Reporter by Mercalis provides best-in-class coverage and reimbursement data to innovative organizations across the life sciences, medical device, diagnostics, provider, and payer industries. Policy Reporter products are designed to help ensure patients can access the therapies they need most. Policy Reporter is a business unit within Mercalis, an integrated life sciences commercialization partner that provides comprehensive solutions that span the entire healthcare value chain. For more information or a free demo, please visit www.policyreporter.com.

About AccessSync

AccessSync, Inc. is the market leader in Access Realization solutions, helping life sciences teams overcome market access complexity. Empowering teams in biopharmaceutical market access, field sales, field reimbursement, account management, and payer marketing, the AccessSync One platform combines configurable software and process automation with deep market access expertise. We focus exclusively on developing integrated Access Realization solutions for clients ranging from leading life sciences brands to emerging manufacturers that commercialize advanced therapies. For more information, visit www.AccessSync.com.

Contact: 
Landy Townsend
VP, Marketing & Communications
Mercalis
[email protected]

SOURCE Mercalis